Bacterial strains and construction of plasmids.
the complex was pulled down using Streptacin sepharose (GE healthcare). Resins were washed three times with buffer C (20mM Tris HCl pH 7.5, 300mM NaCl, 1mM EDTA, 0.1% (w/v) DDM), and the DotI-DotJ complexes were eluted with 2.5mM desthiobiotin (Sigma-Aldrich) in buffer C.
Purification of R64 TraM complex. TraM complex was purified essentially as described for purification of the DotI-DotJ complex with a couple of modifications: BL21(DE3) pET15b-TraM FL (pNH1609) was employed as host E. coli and affinity purification was carried out using HisSelect resin (Sigma-Aldrich). Resins were washed with 30mM imidazole in buffer C and the TraM complex was eluted with 100mM imidazole in buffer C.
Purification of DotI C and TraM C for crystallization. N-terminally His6-tagged DotI C (residues 73-212 of DotI) was overproduced in E. coli BL21(DE3) from the plasmid pNH1359 and purified. The frozen stock cells were thawed and suspended into 80 ml of buffer (50 mM Tris-HCl pH7.5, 1 mM EDTA) with 2 tablets of protease inhibitor cocktail Complete EDTA free and 22 mg of lysozyme. After incubation at 4°C for 40 min, the cells were sonicated (ASTRASON), and the cell lysate was centrifuged (18,000 g x 15 min at 4°C) to remove cell debris. The supernatant was loaded on a SP-sepharose column (GE Healthcare) equilibrated with 20 mM Tirs-HCl pH8.0. Proteins were eluted with a linear gradient of 0 -2 M NaCl. The fractions containing His-DotI C were loaded on a HiTrap chelating column (GE Healthcare) equilibrated with binding buffer (20 mM Tris-HCl pH7.0, 600 mM NaCl) and eluted using a linear gradient of 1 -500 mM imidazole. The His-tag was then removed using proteolytic cleavage by adding thrombin to the His-DotI C solution and dialyzed overnight against binding buffer at 4°C. The reactant was purified on a HiTrap Benzamidine FF column (GE Healthcare) followed by the HiTrap Chelating column to remove thrombin and non-cleaved His-DotI C . The DotI C solution was loaded on a HiLoad Superdex 75 (26/60) column (GE Healthcare), and eluted with the binding buffer. The peak fractions were pooled and concentrated for further use. The purity of the product was examined by SDS-PAGE and MALDI-TOF mass spectrometry (Voyager DE/PRO).
Se-Met labeled proteins were purified in the same way as for native proteins.
N-terminally His6-tagged TraM C (residues 91-230) was overproduced in E. coli BL21(DE3) from the plasmid pNH1377 and purified as described for DotI C with a few modifications. Buffers at pH 7.0 were employed for all preparation steps. Cleared lysate was subjected to Q-sepharose column (GE Healthcare) and flow through fraction containing His-TraM C was subjected to affinity purification using HisSelect resins (Sigma-Aldrich). The His-TraM C -bound resins were washed with buffer containing 10 mM imidazole and His-TraM C was eluted with buffer containing 100 mM imidazole.
Thrombin His-tag was removed by incubation with thrombin (10 U/mg protein) at 22°C for 30 minutes. Cleaved His-tag and thrombin were removed by passing through benzamidine-sepharose (GE Healthcare) and HisSelect columns.
Intracellular growth assay.
U937 human macrophage-like cells were grown in RPMI 1640 media (Gibco 11875) containing 10% fetal bovine serum (FBS). Semi-confluent cells were treated with 100 ng/ml of phorbol myristate acetate (PMA, Sigma P1585) to differentiate to monocytes for 48 hours. The cells were related into the 24-well tissue culture dishes (Falcon) and were infected with L. pneumophila strains at a multiplicity of infection (MOI) of 2. Uninfected bacteria were removed by washing the cells with 1 ml of DPBS (37°C, Gibco) twice after 1 hour of infection and the cells were incubated in 0.5 ml of pre-warmed (37°C) fresh media containing the serum. The cells were lysed with 1 ml of sterile water at 1, 24, 48 5 and 72 hours after infection. Serial dilutions of the lysates were plated on CYE containing 12.5 g/ml of chloramphenicol to measure colony-forming units (CFUs).
L. pneumophila growth assay of luminescent L. pneumophila in Acanthamoeba castellanii was conducted as previously described 2 with the following modifications. A. castellanii was grown in 25 ml of peptone -yeast extract -glucose media (PYG) 5 in 75 cm 2 tissue culture flasks at 25°C without aeration to confluence (2-3 days). Before an infection experiment, A. castellanii cells were washed 2 times with A. castellanii buffer (Ac buffer; PYG media without peptone -yeast extract -glucose) and seeded onto a 96-well format plate (maker) at 10 5 cells per well in a total volume of 200 µl for 3 hours to let the amoebae adhere. L. pneumophila strains expressing luciferase was added to the wells at a MOI of 2. The infected amoeba was incubated at 37°C, and luminescence was measured at indicated time points using the luminescence microplate reader (Powerscan HT, BioTek). 
